Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aleniglipron for Chronic Weight Management in Adults With Obesity or Overweight
NCT07654361Phase 3Recruiting
- Sponsor
- Gasherbrum Bio
- Start
- Jul 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 3 trial of aleniglipron in obesity, sponsored by Gasherbrum Bio. Started Jul 2026; status: recruiting.
02
Drugs
aleniglipron
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07654361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07654361.